跳至主要内容
临床试验/IRCT2017093017756N30
IRCT2017093017756N30招募中2 期

A clinical trial on clinical response and complications of treatment with interferon alpha 2b in patients with basal cell carcinoma

Vice-chancellery for Research and Technology, Mashhad University of Medicla Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Informed written consent for participation; definitive diagnosis of basal cell carcinoma of skin in pathology; and age 18 years old or above. Exclusion criteria: Morphea-like basal cell carcinoma of skin; nodulo-ulcerative basal cell carcinoma; pregnancy and breast-feeding; previous history of severe complications with interferon alpha 2b; no intent to complete the treatment course; no intent to complete the follow-up period; previous history of cardiovascular disease; previous history of thromboembolic disease; local radiotherapy on the target region; previous history of arsenic exposure; and immune insufficiency.

排除标准

  • 未提供

研究者

发起方
Vice-chancellery for Research and Technology, Mashhad University of Medicla Sciences

相似试验